Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Combined therapy in the treatment of dyslipidemia.

Reiner Z.

Fundam Clin Pharmacol. 2010 Feb;24(1):19-28. doi: 10.1111/j.1472-8206.2009.00764.x. Epub 2009 Aug 14. Review.

PMID:
19682080
2.

Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.

Fazio S.

Clin Ther. 2008 Feb;30(2):294-306. doi: 10.1016/j.clinthera.2008.02.004. Review.

PMID:
18343268
3.

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.

Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M; LCP-AtorFen Investigators.

Clin Ther. 2009 Dec;31(12):2824-38. doi: 10.1016/j.clinthera.2009.12.007.

PMID:
20110022
4.
5.

Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.

Chrysant SG, Ibrahim M.

J Clin Hypertens (Greenwich). 2006 Jul;8(7):493-9; quiz 500-1. Review.

6.

Fibrates in combination with statins in the management of dyslipidemia.

Jacobson TA, Zimmerman FH.

J Clin Hypertens (Greenwich). 2006 Jan;8(1):35-41; quiz 42-3. Review.

7.

A new paradigm for managing dyslipidemia with combination therapy: laropiprant + niacin + simvastatin.

Yiu KH, Cheung BM, Tse HF.

Expert Opin Investig Drugs. 2010 Mar;19(3):437-49. doi: 10.1517/13543781003623223. Review.

PMID:
20141348
8.

Nonstatin therapies for management of dyslipidemia: a review.

Sando KR, Knight M.

Clin Ther. 2015 Oct 1;37(10):2153-79. doi: 10.1016/j.clinthera.2015.09.001. Epub 2015 Sep 26. Review.

PMID:
26412799
9.

Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid.

Schima SM, Maciejewski SR, Hilleman DE, Williams MA, Mohiuddin SM.

Expert Opin Pharmacother. 2010 Apr;11(5):731-8. doi: 10.1517/14656560903575639. Review.

PMID:
20210682
10.

[Treatment of dyslipidemia: how and when to combine lipid lowering drugs].

Schulz I.

Arq Bras Endocrinol Metabol. 2006 Apr;50(2):344-59. Epub 2006 May 23. Review. Portuguese.

11.

What combination therapy with a statin, if any, would you recommend?

Dujovne CA, Williams CD, Ito MK.

Curr Atheroscler Rep. 2011 Feb;13(1):12-22. doi: 10.1007/s11883-010-0150-3. Review.

PMID:
21107758
12.

[Combined treatment: regimens, indications and safety profile].

Muñiz Grijalvo O, Villar Ortiz J.

Clin Investig Arterioscler. 2013 Jul-Aug;25(3):140-5. doi: 10.1016/j.arteri.2013.06.003. Epub 2013 Jul 21. Spanish.

PMID:
23880257
13.

Targeting dyslipidemia in the metabolic syndrome: an update.

Paraskevas KI, Karatzas G, Pantopoulou A, Iliopoulos DG, Perrea D.

Curr Vasc Pharmacol. 2010 Jul;8(4):450-63. Review.

PMID:
19485929
14.

Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.

Sharma M, Ansari MT, Abou-Setta AM, Soares-Weiser K, Ooi TC, Sears M, Yazdi F, Tsertsvadze A, Moher D.

Ann Intern Med. 2009 Nov 3;151(9):622-30. doi: 10.7326/0003-4819-151-9-200911030-00144. Review.

PMID:
19884623
15.

The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.

Davidson MH.

Expert Opin Pharmacother. 2007 Oct;8(15):2569-78. Review.

PMID:
17931091
17.

Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.

Hou R, Goldberg AC.

Endocrinol Metab Clin North Am. 2009 Mar;38(1):79-97. doi: 10.1016/j.ecl.2008.11.007. Review.

PMID:
19217513
18.

Combination therapy with statins and omega-3 fatty acids.

Nambi V, Ballantyne CM.

Am J Cardiol. 2006 Aug 21;98(4A):34i-38i. Epub 2006 May 30. Review.

PMID:
16919515
19.

Modifying plasma low-density lipoprotein and high-density lipoprotein cholesterol: what combinations are available in the future?

Kastelein JJ.

Am J Cardiol. 2005 Nov 7;96(9A):20K-27K; discussion 34K-35K. Epub 2005 Sep 21.

PMID:
16291010
20.

Managing dyslipidemia in chronic kidney disease.

Harper CR, Jacobson TA.

J Am Coll Cardiol. 2008 Jun 24;51(25):2375-84. doi: 10.1016/j.jacc.2008.03.025. Review.

Supplemental Content

Support Center